Adrian Adams
CIK 1248144 · COB, CEO and President · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
POZN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
640 LEE ROAD
CHESTERBROOK, PA 19355
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TLPH | Director | 22,709 | $1.10 | $25.0K | $0 | 3 | 2026-06-24 |
| AKBA | Director | 236,200 | $0.67 | $157.4K | $170.5K | 10 | 2026-06-22 |
| TALPHERA, INC. (ACRX) Delisted | Director | 11,168 | $0.86 | $9.6K | $614.0K | 15 | 2023-12-13 |
| IPI Legacy Liquidation Co (IMPL) Delisted | COB, CEO and President | 17,203 | $0.24 | $4.1K | $279.8K | 4 | 2023-02-16 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Chief Executive Officer | 3,787,610 | — | — | $1.23M | 4 | 2017-05-12 |
| POZEN INC /NC (POZN) Delisted | Chief Executive Officer | 2,496,359 | — | — | $6.55M | 2 | 2015-11-12 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | CEO and President | 120,134 | — | — | -$1.36M | 7 | 2015-01-30 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Director | 21,000 | — | — | $0 | 6 | 2012-05-17 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | President and CEO | 0 | — | — | $0 | 4 | 2011-05-16 |
| SEPRACOR INC /DE/ (SEPR) Delisted | President & CEO | 241,667 | — | — | $1.05M | 5 | 2009-10-19 |
Recent Filings · Page 5 of 7
63 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-29 | TALPHERA, INC. (ACRX) Delisted | Buy (P) | +75,000 | $614.0K | EDGAR |
| 2013-02-13 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-02-11 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Grant (A) | +73,080 | $0 | EDGAR |
| 2012-12-17 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Buy (P) | +56,000 | $0 | EDGAR |
| 2012-08-10 | — | Mixed | −21,000 | -$651.0K | |
| 2012-05-17 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
| 2011-12-09 | AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-09-20 | — | Grant (A) | — | $0 | |
| 2011-08-17 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | +15,000 | $161.1K | EDGAR |
| 2011-05-25 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.